The hormone replacement therapy market is witnessing substantial growth due to the rising occurrence of hormonal and targeted conditions such as menopause ...

Detailed price information for Sobr Safe Inc (SOBR-Q) from The Globe and Mail including charting and trades.

SOBRsafe, developer of advanced alcohol detection and monitoring technology, has, after its recent expansion into the behavioral <a ...

MedPharm, a global topical and transdermal Contract Development and Manufacturing Organization ("CDMO"), today announced Mr.

Investigators report findings from a phase 3 trial demonstrating that transdermal estradiol patches were as effective as luteinizing hormone-releasing hormone agonists.

Abuse-deterrent transdermal technology can be used to prevent the misuse of drugs with abuse potential, such as fentanyl, by incorporating aversive agents into transdermal patches. Abuse-deterrent ...

Nutriband (NASDAQ: NTRB), a pharmaceutical company with a special focus on transdermal technologies, is announcing that its patent application, which protects its AVERSA(TM) abuse deterrent ...

Notice of Allowance received from Chinese National Intellectual Property Administration (CNIPA) for the patent application covering its Platform AVERSA™ abuse deterrent transdermal technology ...

Discover Agile Therapeutics' patented transdermal drug delivery device, designed to reduce skin irritation and enhance stability for effective seven-day wear.

Nutriband (NASDAQ: NTRB), a company engaged in the development of prescription transdermal pharmaceutical products, has signed a trademark licensing agreement for the use of Bitrex(R) brand denatonium ...

As the FDA prepares to render a verdict on BMS’ closely watched schizophrenia drug, BioSpace takes a closer look at the ...